BARONI, GIANNA
 Distribuzione geografica
Continente #
EU - Europa 1.410
NA - Nord America 1.196
AS - Asia 133
AF - Africa 3
Totale 2.742
Nazione #
US - Stati Uniti d'America 1.192
PL - Polonia 904
IE - Irlanda 122
SE - Svezia 121
IT - Italia 104
HK - Hong Kong 59
DE - Germania 47
UA - Ucraina 39
CN - Cina 28
BE - Belgio 21
FI - Finlandia 21
JO - Giordania 16
VN - Vietnam 16
GB - Regno Unito 15
CH - Svizzera 9
TR - Turchia 6
CA - Canada 4
SG - Singapore 4
IN - India 3
EG - Egitto 2
ES - Italia 2
FR - Francia 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
JP - Giappone 1
SC - Seychelles 1
Totale 2.742
Città #
Warsaw 904
Fairfield 192
Dublin 122
Chandler 106
Ashburn 95
Woodbridge 88
Seattle 81
Cambridge 76
Houston 72
Jacksonville 67
Ann Arbor 63
Wilmington 52
Lawrence 36
Altamura 34
Hong Kong 34
Florence 33
Princeton 31
Bremen 21
Brussels 21
Beijing 18
Medford 18
Boston 17
San Diego 17
Dong Ket 16
Boardman 15
Buffalo 14
New York 10
Bern 9
Norwalk 6
Shanghai 6
Izmir 5
London 4
Phoenix 4
Rome 4
Toronto 4
Verona 4
Falls Church 3
Los Angeles 3
Münster 3
Bani Suwayf 2
Barcelona 2
Castelfranco Di Sopra 2
Chennai 2
Hillsboro 2
Moscow 2
Nanchang 2
Salerno 2
San Giovanni Rotondo 2
Singapore 2
Trumbull 2
Acton 1
Bologna 1
Brno 1
Covo 1
Genoa 1
Hefei 1
Miami Beach 1
Milan 1
Mirano 1
New Bedfont 1
Redmond 1
Tappahannock 1
Venezia 1
Washington 1
Totale 2.344
Nome #
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 245
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 210
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 196
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 195
Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix. An investigation using CDX-2 and a limited immunohistochemical panel. 192
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 179
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 161
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer 119
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 106
CDX-2 homeobox gene expression. 99
Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. 93
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 78
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. 77
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis. 75
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 71
Epstein-Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma 69
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 61
Cervix adenocarcinoma and squamous cell carcinoma: 2 different morphologicentities? 57
Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. 57
Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis 52
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis 52
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 45
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy 43
Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations 42
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. 40
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 40
Extra-mammary Paget's disease. An HPV-correlated neoplasia? 40
HPV and p53 in urinary bladder carcinoma. 36
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 29
Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues 13
Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues 10
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 7
A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues 2
Totale 2.791
Categoria #
all - tutte 7.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019191 0 0 0 0 0 0 0 0 0 41 85 65
2019/2020600 39 67 25 46 69 58 54 77 55 44 61 5
2020/2021455 37 45 22 59 18 40 24 40 41 77 19 33
2021/2022245 10 31 16 6 9 13 8 19 7 15 38 73
2022/2023572 45 106 42 39 49 93 82 20 65 5 14 12
2023/2024170 7 29 32 10 13 25 6 44 3 1 0 0
Totale 2.791